Related Experiment Video

Updated: May 13, 2026

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

The regulatory roles of phosphatases in cancer

J Stebbing1, L C Lit1, H Zhang1

  • 1Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK.

Oncogene
|March 19, 2013
PubMed

Insights

Phosphatases, crucial for cell control, are under-studied in cancer. Their dysregulation, like PTEN loss, drives malignancies, highlighting their potential as therapeutic targets and biomarkers.

Area of Science:

  • Cellular and Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Post-translational modifications regulate cellular processes, with kinases and phosphatases maintaining cellular equilibrium.
  • Alterations in this balance are implicated in cancer development and progression.
  • Phosphatases, despite their importance, remain relatively under-studied compared to kinases.

Purpose of the Study:

  • To provide an updated review on the role of phosphatase dysregulation in organ-specific malignancies.
  • To highlight the significance of phosphatases in cancer biology and their potential as therapeutic targets.

Main Methods:

  • Literature review focusing on phosphatase dysregulation in cancer.
  • Analysis of existing data on specific phosphatases, such as PTEN (phosphatase and tensin homologue deleted on chromosome 10).
  • Discussion of the implications for targeted therapies and biomarker development.

Main Results:

  • Loss of tumor suppressor phosphatases, exemplified by PTEN, is observed across various tumor types.
  • This loss supports the development of targeted therapies like phosphatidylinositol 3-kinase inhibitors.
  • Phosphatase expression presents potential as a biomarker for cancer, though further clinical validation is needed.

Conclusions:

  • Phosphatase dysregulation is a critical factor in the development and progression of organ-specific cancers.
  • Targeting phosphatases and utilizing their expression as biomarkers represent promising avenues for cancer treatment and diagnosis.

More Related Videos

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...